Great presentation by @AndrearicFili at #ESMO26, bringing the radiation oncology perspective to the debate on borderline resectable stage III NSCLC.
The key question: How do we ensure that every patient get effective curative-intent local treatment in the era of neoadjuvant chemo-IO?
Surgery or Ch-RT? Patient selection and multidisciplinary decision-making remain crucial!
#ESMOAmbassador #LungCancer #NSCLC